{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Turkey Airports & Air Services news", "home_page_url": "https://sharemaestro.com/newsreel/tr/industrials/airports-air-services/", "feed_url": "https://sharemaestro.com/newsreel/tr/industrials/airports-air-services/feed.json", "description": "Latest Airports & Air Services company headlines from Turkey, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:e36d474eb97ad2c336075d3dfe5a331dd95140d361056163840fbc0c12cb09bc", "url": "https://finance.yahoo.com/markets/stocks/articles/changes-full-guidance-biomar-113300186.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/changes-full-guidance-biomar-113300186.html", "title": "Changes to full-year guidance for BioMar", "content_text": "Aktieselskabet Schouw & Co. Today, BioMar has released an announcement with updated guidance for the full year 2026. BioMar now expects revenue in the range of DKK 17-18 billion against previously DKK 16-17 billion and EBIT in the range of DKK 1,200-1,300 million compared to previously DKK 1,100-1,200 million. BioMar constitutes a material part of the portfolio and is fully consolidated into the Schouw & Co. figures, and the information from BioMar will be incorporated into Schouw & Co.'s guidance. Schouw & Co. provides guidance to the market on revenue and EBITDA and will consider its consoli", "date_published": "2026-08-12T11:33:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Guidance", "DOCO"], "_sharemaestro": {"country": "Turkey", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "DOCO", "name": "DO & CO Aktiengesellschaft", "sentiment_url": "https://sharemaestro.com/sentiment/57a46369-0f5f-487b-81b0-b989bb3b4e72/"}]}}, {"id": "source:71a851c14fd85444c47c17893916ebe1b0fe76ccc4bc8e8a0c6e38fcf0f08afb", "url": "https://finance.yahoo.com/markets/stocks/articles/technotrans-se-wbo-ttr1-q2-010228002.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/technotrans-se-wbo-ttr1-q2-010228002.html", "title": "technotrans SE (WBO:TTR1) (Q2 2026) Earnings Call Highlights: Margin Resilience and Strategic ...", "content_text": "This article first appeared on GuruFocus. Revenue: EUR113.3 million in H1 2026, down 6% from EUR120.6 million in the prior year. EBIT: EUR8.0 million in H1 2026, compared to EUR8.4 million one year ago. EBIT Margin: Increased to 7.1% from 7.0% in the prior year. Gross Profit: EUR34.2 million, with gross margin improving to 30.2% from 29.8%. EBITDA: EUR11.2 million, compared to EUR11.9 million in the previous year; EBITDA margin rose to 9.9% from 9.8%. Net Profit: EUR4.9 million, down from EUR5.2 million in the prior year. Earnings Per Share: EUR0.71, compared to EUR0.75 in the previous year. F", "date_published": "2026-08-12T01:02:28+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "DOCO"], "_sharemaestro": {"country": "Turkey", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "DOCO", "name": "DO & CO Aktiengesellschaft", "sentiment_url": "https://sharemaestro.com/sentiment/57a46369-0f5f-487b-81b0-b989bb3b4e72/"}]}}, {"id": "source:307c68c8377bcf013ad783581ce907b734df56f45e0558685346ed0bf0510ade", "url": "https://finance.yahoo.com/healthcare/articles/regn-soars-21-9-month-143000494.html", "external_url": "https://finance.yahoo.com/healthcare/articles/regn-soars-21-9-month-143000494.html", "title": "REGN Soars 21.9% in a Month: Buy, Sell or Hold the Stock?", "content_text": "The going has been strong for Regeneron Pharmaceuticals REGN over the past month. Shares of this biotech giant have surged 21.9% over the said time frame, outpacing the industry's growth of 4%. The stock has also outperformed the sector and the S&P 500 Index during this time. REGN's robust rally has been driven by better-than-expected quarterly results, which can be attributed to robust demand for Eylea HD (higher dose of Eylea) and higher profit-sharing from Dupixent that helped the company mitigate the decline in Eylea sales. REGN Outperforms Industry, Sector and S&P 500 IndexZacks Investmen", "date_published": "2026-08-11T14:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "DOCO"], "_sharemaestro": {"country": "Turkey", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "DOCO", "name": "DO & CO Aktiengesellschaft", "sentiment_url": "https://sharemaestro.com/sentiment/57a46369-0f5f-487b-81b0-b989bb3b4e72/"}]}}]}